LOAME
SLN
Lombard Odier Asset Management (Europe)’s Silence Therapeutics SLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,238,039
| Closed | -$48.3M | – | 289 |
|
|
2024
Q1 | $48.3M | Sell |
2,238,039
-1,374,838
| -38% | -$29.7M | 2.91% | 2 |
|
|
2023
Q4 | $62.8M | Buy |
3,612,877
+168,965
| +5% | +$2.93M | 3.64% | 1 |
|
|
2023
Q3 | $33.8M | Buy |
3,443,912
+28,552
| +0.8% | +$280K | 1.73% | 5 |
|
|
2023
Q2 | $18.8M | Buy |
3,415,360
+121,955
| +4% | +$671K | 0.88% | 37 |
|
|
2023
Q1 | $20.4M | Buy |
3,293,405
+75,205
| +2% | +$466K | 1.01% | 25 |
|
|
2022
Q4 | $49.1M | Sell |
3,218,200
-1,200
| -0% | -$18.3K | 1.99% | 8 |
|
|
2022
Q3 | $32.3M | Buy |
+3,219,400
| New | +$32.3M | 1.68% | 9 |
|
|
2022
Q2 | – | Sell |
-1,561,551
| Closed | -$29.7M | – | 261 |
|
|
2022
Q1 | $29.7M | Buy |
+1,561,551
| New | +$29.7M | 1.14% | 25 |
|